3-196471855-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_152617.4(RNF168):āc.1680A>Gā(p.Lys560Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00145 in 1,613,996 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.0011 ( 1 hom., cov: 32)
Exomes š: 0.0015 ( 5 hom. )
Consequence
RNF168
NM_152617.4 synonymous
NM_152617.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.815
Genes affected
RNF168 (HGNC:26661): (ring finger protein 168) This gene encodes an E3 ubiquitin ligase protein that contains a RING finger, a motif present in a variety of functionally distinct proteins and known to be involved in protein-DNA and protein-protein interactions. The protein is involved in DNA double-strand break (DSB) repair. Mutations in this gene result in Riddle syndrome. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 3-196471855-T-C is Benign according to our data. Variant chr3-196471855-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 718274.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.815 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNF168 | NM_152617.4 | c.1680A>G | p.Lys560Lys | synonymous_variant | 6/6 | ENST00000318037.3 | NP_689830.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNF168 | ENST00000318037.3 | c.1680A>G | p.Lys560Lys | synonymous_variant | 6/6 | 1 | NM_152617.4 | ENSP00000320898.3 | ||
RNF168 | ENST00000437070.1 | n.*1252A>G | non_coding_transcript_exon_variant | 5/5 | 2 | ENSP00000396712.1 | ||||
RNF168 | ENST00000437070.1 | n.*1252A>G | 3_prime_UTR_variant | 5/5 | 2 | ENSP00000396712.1 |
Frequencies
GnomAD3 genomes AF: 0.00110 AC: 167AN: 152166Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
167
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000775 AC: 195AN: 251464Hom.: 0 AF XY: 0.000802 AC XY: 109AN XY: 135904
GnomAD3 exomes
AF:
AC:
195
AN:
251464
Hom.:
AF XY:
AC XY:
109
AN XY:
135904
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00148 AC: 2168AN: 1461712Hom.: 5 Cov.: 32 AF XY: 0.00145 AC XY: 1054AN XY: 727162
GnomAD4 exome
AF:
AC:
2168
AN:
1461712
Hom.:
Cov.:
32
AF XY:
AC XY:
1054
AN XY:
727162
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00110 AC: 167AN: 152284Hom.: 1 Cov.: 32 AF XY: 0.000980 AC XY: 73AN XY: 74478
GnomAD4 genome
AF:
AC:
167
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
73
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
RNF168-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 23, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at